QuidelOrtho Taps Teva Alum Sanjeev Sharma to Lead Investor Relations

Sharma transitions to the role following a tenure as Senior Director of Investor Relations at Teva Pharmaceuticals, where he managed strategic communication during a phase of corporate transformation. His professional background spans more than two decades, including over ten years at Genpact in various strategy roles and nearly six years in sell-side equity research. He holds a master’s degree in finance and is a Chartered Financial Analyst.

QuidelOrtho Chief Financial Officer Micah Young noted that Sharma’s specific blend of capital markets perspective and healthcare industry experience will be instrumental in articulating the company's evolving narrative. Sharma, for his part, emphasized his intent to align the company’s strategic priorities with the expectations of the investment community as QuidelOrtho works to scale its global diagnostics portfolio.